BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34598719)

  • 1. Health system and patient-level factors serving as facilitators and barriers to rheumatic heart disease care in Sudan.
    Edwards JG; Barry M; Essam D; Elsayed M; Abdulkarim M; Elhossein BMA; Mohammed ZHA; Elnogomi A; Elfaki ASE; Elsayed A; Chang AY
    Glob Health Res Policy; 2021 Oct; 6(1):35. PubMed ID: 34598719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study.
    Voleti S; Okello E; Murali M; Sarnacki R; Majwala A; Ssembatya R; Bakka O; Namisanvu H; Njeri A; Matovu A; DeStigter K; Sable C; Beaton A
    BMC Pregnancy Childbirth; 2020 Oct; 20(1):611. PubMed ID: 33036571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
    Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
    Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.
    Belay W; Dessie A; Ahmed H; Gedlu E; Mariyo A; Shehibo A; Tigabu Z; Aliyu MH; Soslow J
    BMC Cardiovasc Disord; 2022 Feb; 22(1):26. PubMed ID: 35109807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatic Heart Disease Treatment Cascade in Uganda.
    Longenecker CT; Morris SR; Aliku TO; Beaton A; Costa MA; Kamya MR; Kityo C; Lwabi P; Mirembe G; Nampijja D; Rwebembera J; Sable C; Salata RA; Scheel A; Simon DI; Ssinabulya I; Okello E
    Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29133472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial).
    Rwebembera J; Ndagire E; Carvalho N; Webel AR; Sable C; Okello E; Sarnacki R; Spaziani AM; Mucunguzi A; Engelman D; Grobler A; Steer A; Beaton A
    Am Heart J; 2024 May; 275():74-85. PubMed ID: 38797460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Out-of-pocket expenditure for administration of benzathine penicillin G injections for secondary prophylaxis in patients with rheumatic heart disease: A registry-based data from a tertiary care center in Northern India.
    Arvind B; Saxena A; Kazi DS; Bolger AF
    Indian Heart J; 2021; 73(2):169-173. PubMed ID: 33865513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to secondary prevention of rheumatic fever and rheumatic heart disease in young people: an 11-year retrospective study.
    Liaw J; Gorton S; Heal C; White A
    Aust N Z J Public Health; 2022 Dec; 46(6):758-763. PubMed ID: 35616403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
    Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
    Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How accurate is the diagnosis of rheumatic fever in Egypt? Data from the national rheumatic heart disease prevention and control program (2006-2018).
    Ghamrawy A; Ibrahim NN; Abd El-Wahab EW
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008558. PubMed ID: 32804953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sharing success - understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease.
    Chamberlain-Salaun J; Mills J; Kevat PM; Rémond MG; Maguire GP
    BMC Cardiovasc Disord; 2016 Aug; 16(1):166. PubMed ID: 27581750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
    Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
    Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatic heart disease in Timor-Leste school students: an echocardiography-based prevalence study.
    Davis K; Remenyi B; Draper AD; Dos Santos J; Bayley N; Paratz E; Reeves B; Appelbe A; Cochrane A; Johnson TD; Korte LM; Do Rosario IM; Da Silva Almeida IT; Roberts KV; Carapetis JR; Francis JR
    Med J Aust; 2018 Apr; 208(7):303-307. PubMed ID: 29642817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease.
    Ketema EB; Gishen NZ; Hailu A; Leul A; Hadgu A; Hagos K; Berhane S; Tsega T; Page-Sharp M; Davis TM; Moore B; Batty KT; Carapetis J; Salman S; Manning L
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009399. PubMed ID: 34115748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review.
    Kevat PM; Reeves BM; Ruben AR; Gunnarsson R
    Curr Cardiol Rev; 2017; 13(2):155-166. PubMed ID: 28093988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué.
    Watkins D; Zuhlke L; Engel M; Daniels R; Francis V; Shaboodien G; Kango M; Abul-Fadl A; Adeoye A; Ali S; Al-Kebsi M; Bode-Thomas F; Bukhman G; Damasceno A; Goshu DY; Elghamrawy A; Gitura B; Haileamlak A; Hailu A; Hugo-Hamman C; Justus S; Karthikeyan G; Kennedy N; Lwabi P; Mamo Y; Mntla P; Sutton C; Mocumbi AO; Mondo C; Mtaja A; Musuku J; Mucumbitsi J; Murango L; Nel G; Ogendo S; Ogola E; Ojji D; Olunuga TO; Redi MM; Rusingiza KE; Sani M; Sheta S; Shongwe S; van Dam J; Gamra H; Carapetis J; Lennon D; Mayosi BM
    Cardiovasc J Afr; 2016 May/Jun 23; 27(3):184-187. PubMed ID: 26815006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic penicillin by the full moon: a novel approach in Central Australia that may help to reduce the risk of rheumatic heart disease.
    Kearns TM; Schultz R; McDonald V; Andrews RM
    Rural Remote Health; 2010; 10(3):1464. PubMed ID: 20795756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health system costs of rheumatic heart disease care in South Africa.
    Hellebo AG; Zuhlke LJ; Watkins DA; Alaba O
    BMC Public Health; 2021 Jul; 21(1):1303. PubMed ID: 34217236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatic heart disease awareness in the South West region of Cameroon: A hospital based survey in a Sub-Saharan African setting.
    Nkoke C; Luchuo EB; Jingi AM; Makoge C; Hamadou B; Dzudie A
    PLoS One; 2018; 13(9):e0203864. PubMed ID: 30252868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening.
    Culliford-Semmens N; Tilton E; Webb R; Lennon D; Paku B; Malcolm J; French S; Blair N; Wilson N
    N Z Med J; 2017 Jun; 130(1457):50-57. PubMed ID: 28617789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.